NNFTF yields 2.35% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, NNFTF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NNFTF + MRK for your $10,000?
Nanofilm Technologies International Limited, together with its subsidiaries, provides nanotechnology solutions in Singapore, China, Japan, and Vietnam. The company operates through three segments: Advanced Materials, Industrial Equipment, and Nanofabrication. The Advanced Materials segment offers advanced materials through surface solution services based on its vacuum coating technologies and processes. The Industrial Equipment segment manufactures and sells turnkey equipment systems comprising coating equipment, cleaning lines, and automation systems that are installed at its customers' production lines. This segment also provides customized operating software for its systems and training, as well as spare-parts, customer service, and other forms of after-sales support. The Nanofabrication segment manufactures and supplies nanoproducts, which are used by its customers as components for the smooth functioning and performance of various parts of their end-products. The company is also involved in the marketing and sale of industrial machinery and equipment; research and experimental development on engineering; research and development, engineering, and production hydrogen application and products; manufacture and supply of dies, moulds, tools, jigs, and fixtures; and provision of coating services to end users in the precision engineering and printed circuit boards industry, as well as coating services for precision components and automotive parts. In addition, it engages in solar cell business; the provision of consultation and technical development services; the manufacture and forming of modules; manufacture, processing, and assembly of plastic products; production and sale of auto parts; and trading and sale of electronics and equipment. The company was incorporated in 1999 and is headquartered in Singapore.
Full NNFTF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.